Hyperplasia collateral-activating pill for treating knee osteoarthritis

The invention discloses a hyperplasia collateral-activating pill for treating knee osteoarthritis. The hyperplasia collateral-activating pill is prepared by the following active pharmaceutical ingredients by weight: 50-65 parts of pseudo-ginseng, 50-65 parts of angelica sinensis, 60-80 parts of clematis roots, 55-65 parts of teasel roots, 55-75 parts of vinegar rhizoma corydalis, 45-65 parts of wine cornus, 45-65 parts of roots of common peony, 55-70 parts of herba siegesbeckiae, 45-60 parts of radix aconiti preparata, 55-70 parts of fissistigma polyanthum, 50-65 parts of ground beeltle, 55-65 parts of myrrh, 55-70 parts of roots of large-leaved gentian, 20-40 parts of manchurian wild ginger, 45-60 parts of honey-fried licorice roots and 45-60 parts of prepared kusnezoff monkshood roots. When the hyperplasia collateral-activating pill is applied to clinical treatment, diagnosis and treatment based on an overall analysis of the illness and the conditions of patients can be achieved, and the knee osteoarthritis can be treated according to etiological factors. After the patients take the hyperplasia collateral-activating pill for ten days, clinical symptoms of the patients are reduced, pain is alleviated, treatment time of patients is effectively shortened, curative effect is obvious, and the total efficiency is as high as 95%.